Mohsin Kapdi
2026
AutoForest: Automatically Generating Forest Plots from Biomedical Studies with End-to-End Evidence Extraction and Synthesis
Massimiliano Pronesti | Angelo Miculescu | Mohsin Kapdi | Paul Flanagan | Oisín Redmond | Joao H Bettencourt-Silva | Gurdeep Singh Mannu | Spiros Denaxas | Rui Providencia | Anya Belz | Yufang Hou
Proceedings of the 64th Annual Meeting of the Association for Computational Linguistics (Volume 3: System Demonstrations)
Massimiliano Pronesti | Angelo Miculescu | Mohsin Kapdi | Paul Flanagan | Oisín Redmond | Joao H Bettencourt-Silva | Gurdeep Singh Mannu | Spiros Denaxas | Rui Providencia | Anya Belz | Yufang Hou
Proceedings of the 64th Annual Meeting of the Association for Computational Linguistics (Volume 3: System Demonstrations)
Systematic reviews rely on forest plots to synthesise quantitative evidence across biomedical studies, but generating them remains a fragmented and labour-intensive process. Researchers must interpret complex clinical texts, manually extract outcome data from trials, define appropriate interventions and comparators, harmonise inconsistent study designs, and carry out meta-analytic computations—typically using specialised software that demands structured inputs and domain expertise. While recent work has demonstrated that large language models can extract study-level data from unstructured text, no existing system automates the complete pipeline from raw documents to synthesised forest plots. To address this gap, we introduce AutoForest, the first end-to-end system that generates publication-ready forest plots directly from biomedical papers. Given one or more study papers, AutoForest automatically suggests ICO (Intervention, Comparator, Outcome) elements, extracts outcome data, performs statistical synthesis, and renders the final forest plot. We describe the system architecture, user interface and demonstrate its effectiveness on real-world examples through a user study involving clinicians, showing how AutoForest can accelerate evidence synthesis and substantially lower the barrier to conducting meta-analyses.